MAOB and Parkinson disease: Consequently, selegiline may also augment the central hypotensive effect of levodopa by increasing dopamine availability through MAO-B inhibition [73], and it was shown that the withdrawal of selegiline suppresses the orthostatic blood pressure reaction in advanced PD patients [68].